Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Nippon Express (China) Opens New Healthcare Branch in Shanghai 2022-08-01 14:22
Nippon Express (China) Opens New Healthcare Branch in Shanghai 2022-08-01 14:17
HanAll Biopharma Reports Second Quarter 2022 Results and Provides Business Update 2022-07-29 20:00
QT MEDICAL'S Online Order, Mail Delivery, XPRESS ECG Testing Service, to Exhibit at the World's Largest Annual Trade Show 2022-07-29 12:22
Daewoong Pharmaceutical Co., Ltd. revs up the growth engine for Nabota, achieving the highest quarterly performance ever 2022-07-28 21:00
The Clinician and Clalit Health Services partner to drive value-based care and digital care pathway implementation in Israel 2022-07-28 12:33
Plant-Oil-Based Skincare Technology Business Available for License or Purchase 2022-07-28 05:22
Samsung Biologics Reports Second Quarter 2022 Financial Results 2022-07-27 14:43
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre 2022-07-26 17:04
Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program 2022-07-25 21:59
Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA 2022-07-25 18:47
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada 2022-07-22 07:59
ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities 2022-07-21 08:00
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug 2022-07-20 21:00
Ascentage Pharma and Innovent Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML 2022-07-20 00:15
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer 2022-07-19 20:00
OliPass Moves Forward to Second Stage of Phase 2a Trial for Pain Killer OLP-1002 2022-07-18 20:00
Samsung Biologics to purchase land for its second Bio Campus 2022-07-18 19:00
Everest Medicines Announces European Commission Grants Approval of Kinpeygo® for Adults with Primary IgA Nephropathy to our Partner Calliditas Therapeutics 2022-07-18 08:00
China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth's NR082 in LHON 2022-07-15 21:00
1 72 73 74 75 76 165